Protocol for a multicenter randomized controlled trial to assess the usefulness of computer-aided detection systems for colonoscopy in colorectal cancer screening in the Asia-Pacific region (project CAD/NCCH2217).

IF 2.2 4区 医学 Q3 ONCOLOGY Japanese journal of clinical oncology Pub Date : 2025-07-06 DOI:10.1093/jjco/hyaf043
Masau Sekiguchi, Kensuke Shinmura, Kazuki Sumiyama, Takahisa Matsuda, Kyung S Han, Hyun-Soo Kim, Han-Mo Chiu, Chi-Yang Chang, Wei J J Lee, Christopher J L Khor, Louis H-S Lau, Sukit Pattarajierapan, Supakij Khomvilai, Ayako Miyata, Taro Shibata, Yutaka Saito
{"title":"Protocol for a multicenter randomized controlled trial to assess the usefulness of computer-aided detection systems for colonoscopy in colorectal cancer screening in the Asia-Pacific region (project CAD/NCCH2217).","authors":"Masau Sekiguchi, Kensuke Shinmura, Kazuki Sumiyama, Takahisa Matsuda, Kyung S Han, Hyun-Soo Kim, Han-Mo Chiu, Chi-Yang Chang, Wei J J Lee, Christopher J L Khor, Louis H-S Lau, Sukit Pattarajierapan, Supakij Khomvilai, Ayako Miyata, Taro Shibata, Yutaka Saito","doi":"10.1093/jjco/hyaf043","DOIUrl":null,"url":null,"abstract":"<p><p>Ensuring the high quality of colonoscopies in colorectal cancer (CRC) screening is essential to reducing CRC. Recently, computer-aided detection systems (CADe) that use artificial intelligence have attracted much attention as potentially useful tools for improving lesion detection in colonoscopy. However, evidence on the efficacy of CADe in CRC screening is lacking. We have planned a multi-national, multi-center, randomized controlled trial in the Asia-Pacific region to assess whether colonoscopy with CADe (test method) yields higher lesion detection (primary endpoint: adenoma detection rate) than colonoscopy without CADe (standard method) in CRC screening populations. The study will include 1400 participants aged 50-79 years who are due to undergo colonoscopy for CRC screening, whether as a primary screening colonoscopy or following a positive fecal immunochemical test. If the efficacy of CADe is proven from this study, the use of CADe in colonoscopy for CRC screening will become standard, leading to improved CRC screening.</p>","PeriodicalId":14656,"journal":{"name":"Japanese journal of clinical oncology","volume":" ","pages":"837-840"},"PeriodicalIF":2.2000,"publicationDate":"2025-07-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Japanese journal of clinical oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/jjco/hyaf043","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Ensuring the high quality of colonoscopies in colorectal cancer (CRC) screening is essential to reducing CRC. Recently, computer-aided detection systems (CADe) that use artificial intelligence have attracted much attention as potentially useful tools for improving lesion detection in colonoscopy. However, evidence on the efficacy of CADe in CRC screening is lacking. We have planned a multi-national, multi-center, randomized controlled trial in the Asia-Pacific region to assess whether colonoscopy with CADe (test method) yields higher lesion detection (primary endpoint: adenoma detection rate) than colonoscopy without CADe (standard method) in CRC screening populations. The study will include 1400 participants aged 50-79 years who are due to undergo colonoscopy for CRC screening, whether as a primary screening colonoscopy or following a positive fecal immunochemical test. If the efficacy of CADe is proven from this study, the use of CADe in colonoscopy for CRC screening will become standard, leading to improved CRC screening.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
亚太地区评估结肠镜计算机辅助检测系统在结直肠癌筛查中的有效性的多中心随机对照试验方案(CAD/NCCH2217项目)。
确保结直肠癌(CRC)筛查中结肠镜检查的高质量对减少结直肠癌至关重要。最近,使用人工智能的计算机辅助检测系统(CADe)作为改善结肠镜检查中病变检测的潜在有用工具引起了人们的广泛关注。然而,CADe在CRC筛查中的有效性尚缺乏证据。我们计划在亚太地区进行一项多国、多中心、随机对照试验,以评估在结直肠癌筛查人群中,结肠镜检查加CADe(试验方法)是否比结肠镜检查不加CADe(标准方法)的病变检出率更高(主要终点:腺瘤检出率)。该研究将包括1400名年龄在50-79岁之间的参与者,他们将接受结肠镜检查进行结直肠癌筛查,无论是作为初步筛查结肠镜检查还是在粪便免疫化学测试阳性之后。如果本研究证实CADe的有效性,那么CADe在结肠镜检查CRC筛查中的应用将成为标准,从而提高CRC筛查水平。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
3.70
自引率
8.30%
发文量
177
审稿时长
3-8 weeks
期刊介绍: Japanese Journal of Clinical Oncology is a multidisciplinary journal for clinical oncologists which strives to publish high quality manuscripts addressing medical oncology, clinical trials, radiology, surgery, basic research, and palliative care. The journal aims to contribute to the world"s scientific community with special attention to the area of clinical oncology and the Asian region. JJCO publishes various articles types including: ・Original Articles ・Case Reports ・Clinical Trial Notes ・Cancer Genetics Reports ・Epidemiology Notes ・Technical Notes ・Short Communications ・Letters to the Editors ・Solicited Reviews
期刊最新文献
Resolution of peritoneal metastases in CLDN18.2-positive gastric cancer treated with CAPOX plus zolbetuximab. Author's reply to 'Trends in Usage and Drug Costs of Immune-Checkpoint Inhibitors in Japan'. Sacituzumab govitecan in Japanese participants with HR+/HER2- metastatic breast cancer: primary results from the phase II ASCENT-J02 study. The letter to editor regarding 'Trends in Usage and Drug Costs of Immune Checkpoint Inhibitors in Japan'. Postoperative skeletal muscle loss is associated with high fat mass in patients undergoing Esophagectomy for esophageal cancer.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1